TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TMO

Thermo Fisher Scientific Inc

Healthcare · Diagnostics & Research

678.40$ +2.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TMO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +7.5% +12.0% +26.9% +13.4% +9.5% +66.7% +15.1% -4.1% -8.2% +3.1% -9.8%
– +0.2% +4.1% +15.6% +11.5% +0.4% +2.1% +11.5% +30.4% +0.7% -8.7% -10.6%
– +6.7% +6.8% +19.1% +13.8% +0.0% +8.3% +17.3% +33.5% -9.4% +8.3% +3.0%
– – – – – – – – -122.9% – – –
– -255.2% – – -209.3% – – – – – – –
– -1.1% +5.1% +14.3% +49.2% +22.2% +59.2% +71.2% -11.1% -34.1% -5.3% +8.9%
– -90.8% +408.7% +39.7% -83.8% +18.7% +1.5% +1,352.5% -90.2% +138.2% +13.6% -30.7%
– +2.5% -0.9% -0.6% +12.2% +11.7% +13.5% +17.2% +15.2% +14.9% +11.5% +9.1%
– -107.4% +150.0% -40.0% -33.3% +200.0% +0.0% +33.3% +50.0% +0.0% +33.3% -25.0%
– -203.0% – -27.5% -151.4% -9.7% – +224.4% -92.7% -123.7% +1,450.3% –
– -154.6% – +34.7% -158.0% +39.4% – +586.2% -142.7% +28.9% +87.5% –
– – – +64.6% +37.5% -59.7% +2,494.8% -173.9% – -110.9% – –
– +9.2% +13.3% +29.0% +8.2% +6.9% +68.4% +3.0% -1.6% +0.2% +4.9% -13.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?